Provided by Tiger Trade Technology Pte. Ltd.

CLOVER BIO-B

2.540
-0.050-1.93%
Volume:3.92M
Turnover:9.89M
Market Cap:3.30B
PE:-3.19
High:2.590
Open:2.550
Low:2.480
Close:2.590
52wk High:3.180
52wk Low:0.185
Shares:1.30B
HK Float Shares:1.30B
Volume Ratio:1.52
T/O Rate:0.30%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.796
ROE:-648.53%
ROA:-47.64%
PB:-1.75
PE(LYR):-3.19
PS:57.62

Loading ...

10th Zhitong Capital Market Annual Conference Honors Excellence with 25 Awards Unveiled

Stock News
·
Dec 03

Clover Biopharmaceuticals (02197) Announces Monthly Return for October 2025

Bulletin Express
·
Nov 05

Wang Xiaodong: 15th National Games to Help Guangzhou Become a City of Sports for All

Deep News
·
Oct 28

Clover Biopharmaceuticals Appoints Nicholas Jackson as President of Global R&D and Alliances

Reuters
·
Oct 20

Peng Liang Spends CN¥545k On Clover Biopharmaceuticals Stock

Simply Wall St.
·
Oct 18

Hong Kong Stock Alert | CLOVER BIO-B (02197) Opens Up Over 5% on Positive Preliminary Clinical Trial Data

Stock News
·
Oct 15

Clover Biopharmaceuticals Ltd - Increases in Neutralizing Antibodies Observed for Rsv, Hmpv, Piv3

THOMSON REUTERS
·
Oct 14

Clover Announces Positive Phase I Clinical Data for Rsv-Hmpv-Piv3 Combination Vaccines and for Rsv Re-Vaccination in Older Adults

THOMSON REUTERS
·
Oct 14

Clover Biopharmaceuticals Ltd - Rsv+Hmpv±Piv3 Vaccine Candidates to Advance to Phase Ii Trials in First Half of 2026

THOMSON REUTERS
·
Oct 14

CLOVER BIO-B (02197) Announces Positive Phase I Clinical Trial Data for Respiratory Combination Vaccine (RSV-hMPV-PIV3) and RSV Vaccine Booster in Elderly Population

Stock News
·
Oct 14

Clover Biopharmaceuticals Announces Positive Phase I Data for RSV-HMPV-PIV3 Combination Vaccines, Plans Phase II Trials in 2026

Reuters
·
Oct 14

Hong Kong Stock Alert | CLOVER BIO-B (02197) Surges Over 21% Following Announcement of Phase I Clinical Trial Launch for Respiratory Combination Vaccine Candidates

Stock News
·
Oct 02

HK Movers | Biotech Stocks Jump With Biocytogen up 11%

Tiger Newspress
·
Sep 18

Biotech Stocks Rebound. Transthera up 16%; Hightide up 13%; Clover Bio up over 9%; Alphamab up 8%; Zai Lab, Jacobio up over 6%; Mirxes up 5%

Tiger Newspress
·
Sep 12

HK Movers | Biotech Stocks Plunge. Ascletis Pharma down 14%; Clover Bio, Transcenta down over 10%; Beigene, HBM Holdings down over 8%; Jacobio down over 7%

Tiger Newspress
·
Sep 11

Hong Kong Biotech Stocks Continue Strong Performance with Clover Bio-B Surging Over 12%

Deep News
·
Sep 01

Hong Kong Stocks Movement | CLOVER BIO-B (02197) Falls Over 9% After Earnings Release, Interim Adjusted Loss of RMB 97.638 Million, Up 11.89% Year-over-Year

Stock News
·
Aug 28

HK Movers | Biotech Stocks Decline, Clover Biopharmaceuticals Drops Over 14%

Tiger Newspress
·
Aug 27

BRIEF-Clover Biopharmaceuticals Posts H1 Revenue Of RMB3.3 Million

Reuters
·
Aug 27

Clover Biopharmaceuticals' H1 Loss Widens

MT Newswires Live
·
Aug 27